Skip to main content
Equibles
RKDA logo

RKDA · Arcadia Biosciences, Inc.

Track RKDA — free

Use RKDA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about RKDA

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.48 -0.14 (-23.12%) At close · Aug 17
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“We believe that our existing cash and cash equivalents will not be sufficient to meet our anticipated cash requirements for at least the next 12 months from the issuance date of these condensed consolidated financial statements, which raises substantial doubt about the Company's ability to continue as a going concern, and the audit opinion on our 2025 audited consolidated financial statements includes a going concern explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 13, 2026
Market Cap
$1.50M
Shares
2.41M

Arcadia Biosciences, Inc. Earnings Call Transcripts

Every quarterly earnings call for Arcadia Biosciences, Inc. (RKDA) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼69.6% $2.17M −$9.28M '21 Q4 22-03-30 ▲288.9% $3.22M −$4.49M '22 Q1 22-05-12 ▲174.6% $3.86M −$3.78M '22 Q2 22-08-11 ▼33.9% $1.57M −$2.87M '22 Q3 22-11-10 ▼156.7% $ −$4.24M '22 Q4 23-03-30 ▼61.7% $1.23M −$9.38M '23 Q1 23-05-11 ▼66.4% $1.30M $823,000 '23 Q2 23-08-10 ▼17.3% $1.30M −$2.57M '23 Q3 23-11-09 · $627,000 −$2.85M '23 Q4 24-03-28 ▼19.9% $987,000 −$2.42M '24 Q1 24-05-09 ▲0.7% $1.31M $1.06M '24 Q2 24-08-13 ▲18.4% $1.54M −$1.61M '24 Q3 24-12-11 ▲93.8% $1.22M −$4.06M '24 Q4 25-03-20 ▲21.6% $1.20M $2.60M '25 Q1 25-05-08 ▲11.4% $1.46M −$4.46M '25 Q2 25-08-14 LATEST ▼15.3% $1.30M $856,000 '25 Q3 25-11-07
Earnings call
FY25 · Q3
2025-11-07
Arcadia Biosciences, Inc. Q3 FY2025 Earnings Call
Revenue
$1.30M
▼ 15.3% YoY
Diluted EPS
$0.62
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
Arcadia Biosciences, Inc. Q2 FY2025 Earnings Call
Revenue
$1.46M
▲ 11.4% YoY
Diluted EPS
$-3.26
▼ 517.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Arcadia Biosciences, Inc. Q1 FY2025 Earnings Call
Confident tone Zola coconut water growth Balance sheet and cash position Legacy AgTech exit and IP monetization
Revenue
$1.20M
▲ 21.6% YoY
Diluted EPS
$1.90
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-20
Arcadia Biosciences, Inc. Q4 FY2024 Earnings Call
Confident tone Zola growth and distribution Roosevelt Resources transaction GoodWheat divestiture and restructuring
Revenue
$1.22M*
▲ 93.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-12-11
Arcadia Biosciences, Inc. Q3 FY2024 Earnings Call
Confident tone Zola Coconut Water growth GoodWheat divestiture wind-down Distribution expansion
Revenue
$1.54M
▲ 18.4% YoY
Diluted EPS
$-1.18
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-13
Arcadia Biosciences, Inc. Q2 FY2024 Earnings Call
Positive tone Zola Coconut Water growth GoodWheat divestiture Corteva wheat IP transaction
Revenue
$1.31M
▲ 0.7% YoY
Diluted EPS
$0.78
▲ 27.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Arcadia Biosciences, Inc. Q1 FY2024 Earnings Call
Confident tone GoodWheat brand expansion and retail execution Operating expense reduction and path to profitability Zola Coconut Water growth
Revenue
$987,000
▼ 19.9% YoY
Diluted EPS
$-1.78
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-28
Arcadia Biosciences, Inc. Q4 FY2023 Earnings Call
Confident tone GoodWheat brand and distribution growth Zola Coconut Water turnaround Strategic review / transaction process
Revenue
$627,000*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Arcadia Biosciences, Inc. Q3 FY2023 Earnings Call
Revenue
$1.30M
▼ 17.3% YoY
Diluted EPS
$-1.89
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
Arcadia Biosciences, Inc. Q2 FY2023 Earnings Call
Revenue
$1.30M
▼ 66.4% YoY
Diluted EPS
$0.61
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
Arcadia Biosciences, Inc. Q1 FY2023 Earnings Call
Revenue
$1.23M
▼ 61.7% YoY
Diluted EPS
$-10.86
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-30
Arcadia Biosciences, Inc. Q4 FY2022 Earnings Call
Revenue
$*
▼ 156.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Arcadia Biosciences, Inc. Q3 FY2022 Earnings Call
Revenue
$1.57M
▼ 33.9% YoY
Diluted EPS
$-4.67
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Arcadia Biosciences, Inc. Q2 FY2022 Earnings Call
Revenue
$3.86M
▲ 174.6% YoY
Diluted EPS
$-6.81
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Arcadia Biosciences, Inc. Q1 FY2022 Earnings Call
Revenue
$3.22M
▲ 288.9% YoY
Diluted EPS
$-8.09
▼ 283.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-30
Arcadia Biosciences, Inc. Q4 FY2021 Earnings Call
Revenue
$2.17M*
▼ 69.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-15
Arcadia Biosciences, Inc. Q3 FY2021 Earnings Call
Revenue
$2.38M
▲ 656.7% YoY
Diluted EPS
$-4.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-16
Arcadia Biosciences, Inc. Q2 FY2021 Earnings Call
Revenue
$1.41M
▲ 400% YoY
Diluted EPS
$-9.60
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-17
Arcadia Biosciences, Inc. Q1 FY2021 Earnings Call
Revenue
$828,000
▲ 168% YoY
Diluted EPS
$4.40
▼ 62.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-30
Arcadia Biosciences, Inc. Q4 FY2020 Earnings Call
Revenue
$7.13M*
▲ 1613.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-12
Arcadia Biosciences, Inc. Q3 FY2020 Earnings Call
Revenue
$314,000
▼ 19.9% YoY
Diluted EPS
$-24.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-13
Arcadia Biosciences, Inc. Q2 FY2020 Earnings Call
Revenue
$281,000
▲ 38.4% YoY
Diluted EPS
$-41.60
▼ 223.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-13
Arcadia Biosciences, Inc. Q1 FY2020 Earnings Call
Revenue
$309,000
▲ 95.6% YoY
Diluted EPS
$11.60
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-25
Arcadia Biosciences, Inc. Q4 FY2019 Earnings Call
Revenue
$416,000*
▼ 6.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–24 of 24 earnings calls
Key facts CIK 1469443 CUSIP 039014303 13F (30d) 18 filings 18 filers Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)